ICU infections and all-cause hospital mortality rate
Was prevalence of infection associated with outcomes among ICU patients in 2017?
Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HF
Response to the positive findings was tempered, however, by the post hoc nature of the analysis, choice of primary outcome, and inconsistencies...
ICMs detect serious arrhythmias in high-risk post-MI patients: SMART-MI
In patients with modestly reduced left ventricular ejection fraction after MI, implantable monitors detect many times more arrhythmias than usual...
Optimizing screening for asymptomatic Afib
How can we optimize screening for patients with asymptomatic atrial fibrillation (Afib)?
EMPEROR-Preserved: Empagliflozin scores HFpEF breakthrough
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection...
Genetic link may tie cannabis use disorder to severe COVID-19
“These data have important implications for policy regarding vaccination as well as treatment prioritization,” said lead author Dr. Alexander S....
COVID-19: New GI symptoms don’t raise death risk in IBD
International registry data show new onset of GI symptoms is common in IBD patients with COVID-19 regardless of IBD disease status.
Time to positivity doesn’t predict mortality in bloodstream infections with enterococci
ACE-I or ARB therapy in patients with low eGFR
Is it safe to continue angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) therapy in patients whose...
One-third in U.S. had been infected by SARS-CoV-2 through 2020: Study
“We have not turned the corner on COVID-19 and are nowhere near herd immunity – if it exists for SARS-CoV-2.”